Ana Vallari

ORCID: 0000-0003-1129-1977

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay”.

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

medRxiv(2021)10.1101/2021.03.03.21251639

N/A

0.520DataRank · unranked

31 citations

Saki Takahashi, Jill Hakim, J. Daniel Kelly, Leonel Torres, Nikita S. Iyer +40 more

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India

Scientific Reports(2020)10.1038/s41598-020-64309-5

N/A

0.345DataRank · unranked

9 citations

Selvamurthi Gomathi, Ana Vallari, Shanmugam Saravanan, Gregory M. Lucas, Shruti H. Mehta +3 more

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

Science Advances(2021)10.1126/sciadv.abh3409

N/A

0DataRank · unranked

151 citations

Saki Takahashi, Jill Hakim, J. Daniel Kelly, Leonel Torres, Nikita S. Iyer +41 more